GLP-1 / GIP / Glucagon triple agonist
Delivery
ShiLai™ Brand | OEM Available
For B2B, OEM and distribution projects
ShiLai™ Healthcare provides a broad portfolio of established and next-generation peptide products for qualified B2B partners. Our platform combines more than a decade of peptide production experience with single-chamber pre-filled cartridge systems, dual-chamber cartridge technology, OEM/private-label packaging and custom peptide development.
ShiLai™ Brand or Your Brand
Products can be supplied through ShiLai™ branded packaging or developed as OEM/private-label projects for qualified B2B partners. Packaging configurations may include the cartridge system, delivery device, label, inner tray, carton and customized brand presentation.
GLP-1 / GIP / Glucagon triple agonist
Delivery
ShiLai™ Brand | OEM Available
Next-generation amylin receptor agonist
Delivery
ShiLai™ Brand | OEM Available
AOD9604
Anti-obesity peptide fragment
Delivery
ShiLai™ Brand | OEM Available
Tesamorelin
GHRH analogue
Delivery
ShiLai™ Brand | OEM Available
CJC-1295 No DAC
Modified GRF 1-29, GHRH analogue
Delivery
ShiLai™ Brand | OEM Available
Ipamorelin
Selective growth hormone secretagogue
Delivery
ShiLai™ Brand | OEM Available
BPC-157 + TB-500
Body Protection Compound + Thymosin Beta-4 blend
Delivery
ShiLai™ Brand | OEM Available
BPC-157
Body Protection Compound
Delivery
ShiLai™ Brand | OEM Available
TB-500
Thymosin Beta-4 fragment
Delivery
ShiLai™ Brand | OEM Available
KPV
Alpha-MSH fragment, anti-inflammatory
Delivery
ShiLai™ Brand | OEM Available
Thymosin Alpha 1
Immune-modulating peptide (Tα1)
Delivery
ShiLai™ Brand | OEM Available
LL-37
Cathelicidin antimicrobial peptide
Delivery
ShiLai™ Brand | OEM Available
Mitochondrial-derived peptide
Delivery
ShiLai™ Brand | OEM Available
Elamipretide, mitochondria-targeting peptide
Delivery
ShiLai™ Brand | OEM Available
NAD+
Nicotinamide Adenine Dinucleotide
Delivery
ShiLai™ Brand | OEM Available
Epitalon
Epithalamin tetrapeptide, telomere support
Delivery
ShiLai™ Brand | OEM Available
Semax
ACTH 4-7 Pro-Gly-Pro, nootropic peptide
Delivery
ShiLai™ Brand | OEM Available
Selank
Tuftsin analogue, anxiolytic peptide
Delivery
ShiLai™ Brand | OEM Available
DSIP
Delta Sleep-Inducing Peptide
Delivery
ShiLai™ Brand | OEM Available
PT-141
Bremelanotide, melanocortin receptor agonist
Delivery
ShiLai™ Brand | OEM Available
Kisspeptin-10
Hypothalamic neuropeptide
Delivery
ShiLai™ Brand | OEM Available
Melanotan II
MT-2, melanocortin receptor agonist
Delivery
ShiLai™ Brand | OEM Available
Copper peptide, skin & hair regeneration
Delivery
ShiLai™ Brand | OEM Available
Glow Blend
Multi-peptide brightening blend
Delivery
ShiLai™ Brand | OEM Available
Klow Blend
GHK-Cu + complementary peptide blend
Delivery
ShiLai™ Brand | OEM Available
ShiLai™ Healthcare operates as a manufacturing-focused peptide supplier for qualified B2B partners including distributors, OEM brands and research-supply organizations. Our production infrastructure supports both established peptide molecules and next-generation compounds, with in-house analytical capability covering HPLC, LC-MS and endotoxin testing at every batch.
We do not sell to individual consumers. All product inquiries are handled on a B2B basis, with project requirements, target markets and specifications reviewed before supply arrangements are confirmed.
Our peptide portfolio is delivered through two core cartridge platforms. The single-chamber pre-filled cartridge system provides a ready-filled format for streamlined B2B product integration. The dual-chamber cartridge platform separates components within one cartridge system until activation, supporting selected formulation requirements where component separation is relevant.
Both platforms are designed for integration with standard injection pen devices and can be supplied with complete ShiLai™ branded or OEM/private-label packaging for qualified partners.
Qualified B2B partners can develop OEM or private-label peptide products using ShiLai™ manufacturing infrastructure. OEM projects typically involve product specification review, delivery-system selection, packaging design and regulatory documentation support. Private-label options allow partners to present products under their own brand identity.
Packaging configurations for OEM projects may include the cartridge system, injection pen or device, product label, inner tray, branded outer carton and product insert. Custom branding elements are coordinated directly with the partner.
Where a required peptide, specification or cartridge configuration is not available within the standard portfolio, ShiLai™ can discuss custom development options with qualified partners. Custom development may cover novel peptide sequences, non-standard concentrations, custom blend formulations or specific delivery-system configurations.
Custom development projects are assessed on a case-by-case basis. Partners are encouraged to provide the peptide name or sequence, target specification, intended market and estimated volume requirements when making initial contact.
Every peptide batch produced by ShiLai™ Healthcare is subject to in-house analytical testing before release. Standard testing includes HPLC purity analysis, LC-MS molecular weight confirmation and endotoxin testing. A Certificate of Analysis (COA) is provided with each batch, documenting test results against specification.
Our in-house laboratory capability means testing is conducted under the same quality management framework as production, rather than outsourced to a third-party laboratory with separate documentation chains.
The peptide products in this portfolio are available through ShiLai™ cartridge delivery platforms. For detailed technical information on each platform, see the dedicated delivery system pages below.
Our capabilities extend beyond the products listed here. If your required peptide, specification or cartridge configuration is not shown, contact ShiLai™ to confirm availability or discuss a custom peptide development program.
Common questions from B2B partners about our peptide portfolio, OEM options and custom development.